Upfront, I'm long shares of Kenvue (NYSE: KVUE ). After poking around the name a few times following its spin-off from Johnson & Johnson ( JNJ ), I bought the stock amid the first reports that the Trump Administration was seekingI've been contributing to Seeking Alpha and other investment websites since 2011, with a general (though far from rigid) focus on value over growth. I got my Series 7 and 63 back in 1999, and watched the dot-com bubble peak and then burst in real time at a small, tech-focused retail ...

Upfront, I'm long shares of Kenvue (NYSE: KVUE ). After poking around the name a few times following its spin-off from Johnson & Johnson ( JNJ ), I bought the stock amid the first reports that the Trump Administration was seekingI've been contributing to Seeking Alpha and other investment websites since 2011, with a general (though far from rigid) focus on value over growth. I got my Series 7 and 63 back in 1999, and watched the dot-com bubble peak and then burst in real time at a small, tech-focused retail ...

Kenvue (KVUE) faces significant regulatory and reputational headwinds as the Trump administration asserted, without evidence, a definitive link between acetaminophen, the active ingredient in pain reliever Tylenol, and autism during pregnancy. This represents a direct challenge to one of Kenvue's most important revenue drivers within its Self-Care segment, which includes trusted brands such as Tylenol, Motrin, and Benadryl. The consumer health company, spun off from Johnson & Johnson (JNJ) in 2023, has re ...

(Bloomberg) — President Donald Trump created a potentially existential crisis for Tylenol maker Kenvue (KVUE) Inc. with just three words about the company’s most-recognized product: “don’t take it.” Trump’s warnings about the unproven link between Tylenol use during pregnancy to autism in children risks reinvigorating a barrage of litigation over the issue that the company has sought to put behind it. A federal court in December dismissed lawsuits alleging a link between the active ingredient in the over- ...

智通财经APP获悉，针对特朗普政府声称孕期服用止痛药泰诺与儿童自闭症存在关联的说法，世界卫生 组织(WHO)周三基于最新科学证据宣布二者并无联系。 此前，因特朗普政府就自闭症风险问题对泰诺的使用提出质疑，泰诺生产商Kenvue(KVUE.US)股价在 周一暴跌逾7%。而随着科学界澄清质疑，该公司股价已逐步回升。 此外，这家全球性卫生机构还提到，大量科学证据表明疫苗与自闭症之间不存在关联——而美国卫生与 公众服务部部长小罗伯特·F·肯尼迪却曾多次宣扬"疫苗致自闭症"的说法。 世卫组织表示，此前那些声称疫苗与自闭症存在关联的原始研究已被证伪，为该组织提供咨询的独立专 家也反复证实，疫苗与包括自闭症在内的发育障碍之间不存在关联。 周二，欧洲药品管理局(EMA)也表示，目前没有证据表明自闭症与泰诺(又称乙酰氨基酚或扑热息痛)存 在关联。 WHO指出："目前尚无确凿科学证据证实自闭症与孕期使用对乙酰氨基酚之间存在潜在关联。"该组织 同时补充称，这种神经发育障碍的成因可能涉及多种因素。 ...

Ah, the financial markets. A bastion of rational thought, meticulous analysis, and predictable outcomes. Or so the textbooks claim. In the era of former President Donald Trump, however, this venerable institution often resembles a high-stakes game of whack-a-mole, with market movements less dictated by traditional fundamentals and more by a tweet, a press conference, or a sudden, unexpected policy pivot. The past few days alone have offered a masterclass in this unique brand of market volatility, proving on ...

The Nasdaq led declines, with shares of Nvidia down after rising in the previous session, when the chipmaker said it plans to invest up to $100 billion in OpenAI. Amazon.com, Microsoft and Apple also were lower, while shares of AutoZone were down after it reported fourth-quarter profit that missed estimates. In comments Tuesday, Powell offered little hint of when he thinks the Fed might next cut interest rates. The Fed last week cut rates for the first time this year and indicated further cuts may be comin ...

LOGIN SUBSCRIBE | FastCo Works The announcement, which appeared to rely on existing studies rather than significant new research, arrives as Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, advances the Make America Healthy Again movement that has focused on what it sees as potential causes of autism. Subscribe to the Daily newsletter.Fast Company's trending stories delivered to you every day Privacy Policy | Fast Company Newsletters Kenvue disputed any link between the drug an ...

Tylenol once survived a poisoning scandal. Now it has to survive President Donald Trump. Kenvue, the company behind the household brand, at least has a playbook to turn to for guidance. That's because Tylenol's original owner, Johnson & Johnson, developed it decades ago after seven people in the Chicago area died from taking its capsules because someone had laced them with potassium cyanide. The 1982 unsolved mystery became known as the "Tylenol murders."J&J's handling of the incident not only saved the br ...

Kenvue stock is rebounding. It may be a largely a case of things-could've-been- worse. ...